THESE statistics from the Office for National Statistics are important in showing that a cancer diagnosis isn’t a death sentence.
We’ve made progress in diagnosing cancer at early stages, when treatment is more likely to be successful.
It’s good to see improvements in survival for many cancer types, such as lung, ovarian and Hodgkin lymphoma.
Five-year survival from lung cancer, which has previously been stubbornly low, increased from 11 per cent five years ago to 15 per cent in the latest figures.
But there is still a way to go and we haven’t seen this change across the board. There are other cancers, like brain and stomach cancer which have not seen the same increases.
Improving the quantity of research into cancers with the poorest survival rates remains a key priority across all aspects of Cancer Research UK’s work – from funding breakthroughs in biology, to developing a community of world-leading researchers.
This story also highlights the importance of early diagnosis.
When bowel cancer is diagnosed at the earliest stage, more than 9 in 10 people diagnosed will survive their disease for five years or more, compared with around one in 10 for patients diagnosed at the latest stage.
Cancer Research UK is working hard to ensure we see more progress in improving survival for other cancer types in the future. This will help us reach our ambition of three in four people surviving their cancer by 2034.